Dopamine acts both as a neurotransmitter and as a hormone, exerting its function via dopamine receptors that are present in a broad variety of organs and cell systems. Circulating dopamine is primarily stored in and transported by blood platelets. Recently, the important contribution of dopamine in the regulation of angiogenesis has been recognized. In vitro and in vivo studies have shown that dopamine inhibits tumor growth through activation of the dopamine receptor type 2, thereby inhibiting the proangiogenic effects of vascular endothelial growth factor and hypoxia inducible factors. In pheochromocytoma (PCC) and paraganglioma (PGL), however production of dopamine has been shown to be an independent determinant of malignancy. 'In this review, we discuss the role of dopamine in the angiogenesis pathway and the seemingly contradicting relationship between pheochromocytoma-paraganglioma dopamine production and tumor behavior. '
INTRODUCTION
Pheochromocytoma (PCC) and paraganglioma (PGL) are rare neuroendocrine tumors derived from chromaffin cells of adrenal medulla and paraganglia, respectively1. PCC/PGL can be diagnosed by the demonstration of increased catecholamines, preferentially by measurement of their free or unconjugated O-methylated metabolites, i.e. metanephrine, normetanephrine, and 3-methoxytyramine (3-MT) in plasma or urine. Until recently, the biochemical diagnosis of PCC/ PGL was mainly based on demonstrating overproduction of norepinephrine or epinephrine or their respective metabolites, with no special interest in dopamine. In 1956, it was already shown that increased synthesis of dopamine was associated with malignant behavior of PCC/PGL2. The relevance of these early observations was only recently substantiated by the finding of a strong correlation between increased tumor dopamine production and germline mutations of the succinate dehydrogenase (SDH) subunit B (SDHB) gene in malignant PGLs3-5. In 1957, Arvid Carlsson demonstrated that dopamine is a neurotransmitter in the brain, and not merely a precursor for norepinephrine as had been assumed earlier6. Subsequently, it became evident that dopamine has widespread effects in the human body (Table 1) . Interestingly, recent studies showed major effects of dopamine on inhibiting angiogenesis and (tumor)neovascularization7-14. These insights shed new light on dopamine metabolism in relation to tumor angiogenesis and potentially constitute important new targets for treatment15-17. Paradoxically, increased dopamine concentrations are associated with more malignant tumor behavior in PCC/PGL3-5, 18 . In this review, we discuss the roles of dopamine with special focus on its relations with vascular endothelial growth factor (VEGF) and hypoxia inducible factor (HIF) related angiogenesis pathways.
PHYSIOLOGY OF DOPAMINE

Physiological functions of dopamine
Dopamine synthesis and/or storage takes place in a variety of organs (Table 1 ). In the brain, dopamine is involved in several processes such as cognition, motion control, emotion, pain perception, sexual behavior, food intake and rewarding processes19-21. Dopamine does not cross the blood-brain barrier, keeping dopaminergic signaling in the brain functionally separated from peripheral dopamine actions22. Peripheral dopamine-secreting tissues can be categorized into two groups according to the pathway of dopamine biosynthesis. The first group includes tissues like the adrenal medulla and peripheral sympathetic nerves that are able to take up tyrosine. The second group consists of cell systems that actively take up of L-3,4-dihydroxyphenylalanine (L-DOPA) which is then decarboxylated to dopamine inside the cell (Figure 1 ) 20, 23, 24 . Cells that take up L-DOPA were previously designated amine precursor uptake and decarboxylation (APUD) cells23.
By binding to the different dopamine receptors that are present in a variety of organs, dopamine can elicit a broad range of physiological effects. These are also summarized in Table 1 .
Peripheral tissues
Adrenal gland Medulla ( 
Dopamine synthesis
The primary precursor for the catecholamine biosynthesis is tyrosine, which is either absorbed in the gastrointestinal tract from protein-rich foods or formed after hydroxylation of the essential amino acid, phenylalanine25,26. The conversion of phenylalanine to tyrosine occurs in the brain, liver, adrenal medulla, and peripheral sympathetic nerves26. In the cytosol of catecholaminergic neurons and the adrenal medulla, tyrosine is converted to L-DOPA by the enzyme tyrosine hydroxylase (TH, EC 1.14.16.2) (Figure 1 ). The hydroxylation of tyrosine by TH is the rate-limiting step in the dopamine biosynthesis27,28. Conversion of L-DOPA to dopamine is catalyzed by the enzyme aromatic L-amino acid decarboxylase (AADC, EC 4.1.1.28). Depending on the presence and activity of dopamine β-hydroxylase (DBH, EC 1.14.17.1) and phenylethanolamine-N-methyltransferase (PNMT, EC 2.1.1.28), dopamine can be further converted to norepinephrine and epinephrine, respectively27.
The total amount of dopamine that is converted into norepinephrine is tissue-specific and varies 
Cellular dopamine transport
Dopamine storage and release
After its synthesis or reuptake, dopamine is transported from the cytosol into storage vesicles Exercise may cause disruption of this gradient by hypoxia or ischemia, resulting in a rapid release of catecholamines from storage vesicles into the cytoplasm39,42. In patients with a PCC, plasma concentrations of epinephrine, norepinephrine, and dopamine are increased after an exercise test and associated with reduced pH levels43. Additionally, post-exercise levels of epinephrine and the epinephrine/dopamine ratio are elevated in patients with a PCC compared to healthy controls42.
In addition, it has been demonstrated that an increased production of lactate is accompanied by a higher release of norepinephrine in the brain, and it has been suggested that his might contribute to the positive effects of exercise on well-being44. Recently, an alternative pathway for brain norepinephrine release was described that involves lactate produced by astrocytes44. It is not yet clear if this effect is receptor mediated or a direct effect of a lactate induced decrease in pH.
Dopamine reuptake
Acting both as a neurotransmitter and a hormone, dopamine has autocrine/paracrine functions as It is presumed that, when dopamine binds to DAT, together with Na + and Cl -, they promote a change in the conformation of DAT from a primarily outward-facing to a predominantly inward-facing transporter. In sympathetic nerves, dopamine can also be released by exocytosis47. (see color image on page 187)
Dopamine receptors
Cytoplasmatic vesicles store dopamine until an action potential triggers its release through exocytosis. Tissue specific response is mediated through specific dopamine receptors which are expressed in various tissues and cells, as described in Table 1 After exocytosis, dopamine is either retrieved through reuptake into the secreting cell by the dopamine transporter (DAT) (Figure 2 ) as discussed above, or is inactivated by one of the enzymes described in the next section.
Dopamine metabolism
There are three enzymes involved in the metabolism of dopamine: the first is monoamine oxidase 
INTERACTION BETWEEN DOPAMINE AND ANGIOGENESIS
Normal angiogenesis
Angiogenesis is an important adaptive process to guarantee a continuous supply of nutrients and disposal of waste products, such as during embryogenesis or during repair of damaged blood vessels. In addition, angiogenesis is a vital process to prevent hypoxic situations, caused by e.g. An anti-angiogenic effect of dopamine has also been suggested in preclinical models with human cancers. In vivo results with mice bearing ovarian cancer suggested that dopamine reduces chronic stress-mediated cancer growth in ovarian carcinoma64. Dopamine and TH were absent in 
Dopamine and coagulation
In addition to the inhibiting actions of dopamine on hypoxia driven angiogenesis, dopamine also exerts a certain degree of inhibition when angiogenesis is activated by the coagulation system. Hypoxia enhances the transcription of TH as well as the stability of TH mRNA, the key enzyme in catecholamine biosynthesis77,78. This effect of hypoxia is mediated by the HIF complex, which binds to the hypoxia-responsive element (HRE) in the proximal region of the TH promoter of PC12 cells79,80. Moreover, hypoxia was shown to induce HIF-mediated TH mRNA expression in rat mesencephalic cultures81. Injection of desferrioxamine, an iron chelator that also induces the accumulation of HIF-1α, caused TH gene expression in rats82. In addition, it has been found that neuronal precursor cells of HIF-1α knockout mice showed less dopaminergic differentiation and a decrease in expression of dopaminergic marker molecules such as TH and aldehyde dehydrogenase of 41% and 61%, respectively83. Furthermore, in vivo results in chicken embryos showed that TH is also regulated by HIF-2α84.These observations indicate that both HIF-1α and HIF-2α could promote TH gene transcription and dopamine biosynthesis77,85. Transcription of the TH gene is indirectly also regulated by pVHL through its effects on the concentration of HIFs79.
In addition to these in vitro and in vivo results, hypoxia mediated catecholamine release has also been described in the human fetus86,87. Notably, innervation of the adrenal medulla is immature or absent at birth87. The hypoxia mediated catecholamine release by adrenomedullary type 1 cells in the neonate plays a critical role in the ability to survive stressors occurring around delivery and the transition to extrauterine life87. This mechanism is lost postnatally, simultaneously with the maturation of the sympathetic nerves innervating the adrenal medulla87.
The carotid bodies of rats living at high altitude were shown to contain TH and dopamine levels which were 6 and 43 times higher, respectively, than those in age-matched rats at sea level88. In addition, the carotid bodies of these rats contained more chemosensitive cells, fibroblasts, and more blood vessels88. In humans, carotid body tumors were estimated to be about 10 times more frequent in a population living at high altitudes than in a population at sea level due prolonged and severe hypoxia which caused hyperplasia of the chemoreceptor tissue89. In conclusion, parasympathetic and sympathetic paraganglia are oxygen sensitive organs, responding to hypoxia with the release of dopamine, which in turn stimulates the respiratory center.
PCC/PGL are highly associated with hypoxia
Currently, about 35% of PCC/PGLs are considered to be hereditary90. PCC can be part of other 
PCC/PGL and dopamine production
We recently documented the presence of catecholamine synthesizing enzymes in parasympathetic head and neck PGL tissues114. Elevated levels of 3-MT in plasma or urine have been found in 19-28% of patients with a head and neck PGLs115-117. In addition, we have recently demonstrated a higher concentration of dopamine in platelets from patients with head and neck PGLs as compared with healthy controls118.
An increased plasma free 3-MT was demonstrated in 72% percent of patients with a SDHB mutation and 67% of patients with a SDHD mutation119. This increase of dopamine production might be explained by an enhanced TH gene transcription due to an increased HIF-α activity. In the same study, only 17% of patients with VHL disease were found to have an elevated plasma free 3-MT concentration, despite the fact that degradation of HIF-α is also decreased in these patients.
It is unclear how the difference in plasma 3-MT concentration between SDHx and VHL-related PGL tumors can be explained.
Dopamine production predictor for malignancy in PCC/PGL
PCC/PGLs are predominantly benign tumors, but malignancy may occur in up to 10% of all PCC/ PGL120. Malignancy is defined as local invasion or the presence of metastases of chromaffin tissue Figure 6 Proposed mechanism of the interplay between the mitochondrial complex II and fumarate hydratase in the stabilization of the hypoxia-inducible factor (HIF)-α signalling pathway. 
Dopamine in malignant PCC/PGL
As described in the previous sections, dopamine inhibits angiogenesis in preclinical models. It was shown that dopamine inhibits phosphorylation of the VEGF-receptor type and exerts several other antiproliferative effects. It was shown that malignant PCC/PGL give rise to increased plasma 3-MT concentrations. In the next section we discuss several mechanisms by which tumors adapt to the presence of dopamine.
Adaptation to high dopamine levels in carcinomas tissue
Malignant tumors may still grow despite the local production of dopamine with its antitumoral 
